Chem Shift validation: AVS_anomalous, AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR17384
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Campos-Olivas, Ramon; Marenchino, Marco; Scapozza, Leonardo; Gervasio, Francesco. "Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib." Biomol. NMR Assignments 5, 221-224 (2011).
PubMed: 21523440
Assembly members:
SrcKD, polymer, 286 residues, Formula weight is not available
STI, non-polymer, 493.603 Da.
Natural source: Common Name: chicken Taxonomy ID: 9031 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Gallus gallus
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: modifyed pET28
Data type | Count |
13C chemical shifts | 685 |
15N chemical shifts | 215 |
1H chemical shifts | 215 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Src Kinase Domain | 1 |
2 | Imatinib/Gleevec | 2 |
Entity 1, Src Kinase Domain 286 residues - Formula weight is not available
Residues -3 to -1 represent a non-native tag. Residues 251 to 533 correspond to the Src kinase catalytic domain
1 | GLY | HIS | MET | GLN | THR | GLN | GLY | LEU | ALA | LYS | ||||
2 | ASP | ALA | TRP | GLU | ILE | PRO | ARG | GLU | SER | LEU | ||||
3 | ARG | LEU | GLU | VAL | LYS | LEU | GLY | GLN | GLY | CYS | ||||
4 | PHE | GLY | GLU | VAL | TRP | MET | GLY | THR | TRP | ASN | ||||
5 | GLY | THR | THR | ARG | VAL | ALA | ILE | LYS | THR | LEU | ||||
6 | LYS | PRO | GLY | THR | MET | SER | PRO | GLU | ALA | PHE | ||||
7 | LEU | GLN | GLU | ALA | GLN | VAL | MET | LYS | LYS | LEU | ||||
8 | ARG | HIS | GLU | LYS | LEU | VAL | GLN | LEU | TYR | ALA | ||||
9 | VAL | VAL | SER | GLU | GLU | PRO | ILE | TYR | ILE | VAL | ||||
10 | THR | GLU | TYR | MET | SER | LYS | GLY | SER | LEU | LEU | ||||
11 | ASP | PHE | LEU | LYS | GLY | GLU | MET | GLY | LYS | TYR | ||||
12 | LEU | ARG | LEU | PRO | GLN | LEU | VAL | ASP | MET | ALA | ||||
13 | ALA | GLN | ILE | ALA | SER | GLY | MET | ALA | TYR | VAL | ||||
14 | GLU | ARG | MET | ASN | TYR | VAL | HIS | ARG | ASP | LEU | ||||
15 | ARG | ALA | ALA | ASN | ILE | LEU | VAL | GLY | GLU | ASN | ||||
16 | LEU | VAL | CYS | LYS | VAL | ALA | ASP | PHE | GLY | LEU | ||||
17 | ALA | ARG | LEU | ILE | GLU | ASP | ASN | GLU | TYR | THR | ||||
18 | ALA | ARG | GLN | GLY | ALA | LYS | PHE | PRO | ILE | LYS | ||||
19 | TRP | THR | ALA | PRO | GLU | ALA | ALA | LEU | TYR | GLY | ||||
20 | ARG | PHE | THR | ILE | LYS | SER | ASP | VAL | TRP | SER | ||||
21 | PHE | GLY | ILE | LEU | LEU | THR | GLU | LEU | THR | THR | ||||
22 | LYS | GLY | ARG | VAL | PRO | TYR | PRO | GLY | MET | VAL | ||||
23 | ASN | ARG | GLU | VAL | LEU | ASP | GLN | VAL | GLU | ARG | ||||
24 | GLY | TYR | ARG | MET | PRO | CYS | PRO | PRO | GLU | CYS | ||||
25 | PRO | GLU | SER | LEU | HIS | ASP | LEU | MET | CYS | GLN | ||||
26 | CYS | TRP | ARG | LYS | ASP | PRO | GLU | GLU | ARG | PRO | ||||
27 | THR | PHE | GLU | TYR | LEU | GLN | ALA | PHE | LEU | GLU | ||||
28 | ASP | TYR | PHE | THR | SER | THR | GLU | PRO | GLN | TYR | ||||
29 | GLN | PRO | GLY | GLU | ASN | LEU |
Entity 2, Imatinib/Gleevec - C29 H31 N7 O - 493.603 Da.
1 | STI |
sample_1: SrcKD, [U-15N]-Leu, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_2: SrcKD, [U-15N]-Ile, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_3: SrcKD, [U-15N]-Met, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_4: SrcKD, [U-15N]-Phe, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_5: SrcKD, [U-15N]-Val, [U-15N]-Leu, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_6: SrcKD, [U-15N]-Tyr, [U-15N]-Leu, 0.2-0.4 mM; Imatinib/Gleevec 0.3-0.6 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_7: SrcKD, U-98% 15N; U-60% 2H], 0.3-0.6 mM; Imatinib/Gleevec 0.45-0.9 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_8: SrcKD, [U-99% 13C; U-98% 15N; U-92% 2H], 0.3-0.6 mM; Imatinib/Gleevec 0.45-0.9 mM; TRIS 20 mM; sodium choride 0.5 M; sodium azide 0.03%; magnesium chloride 1 mM; TCEP 1 mM; D2O 7%
sample_9: SrcKD, [U-99% 13C; U-98% 15N; U-92% 2H], 0.3-0.6 mM; Imatinib/Gleevec 0.45-0.9 mM; sodium phosphate 20 mM; sodium choride 0.5 M; sodium azide 0.03%; TCEP 1 mM; D2O 7%
sample_conditions_1: ionic strength: 0.541 M; pH: 8.0; pressure: 1 atm; temperature: 293 K
sample_conditions_2: ionic strength: 0.62 M; pH: 6.3; pressure: 1 atm; temperature: 293 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_2 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_3 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_4 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_5 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_6 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_7 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_7 | isotropic | sample_conditions_1 |
4D 1H-15N-1H-15N NOESY | sample_7 | isotropic | sample_conditions_1 |
4D 1H-15N-1H-15N NOESY | sample_7 | isotropic | sample_conditions_1 |
4D 1H-15N-1H-15N NOESY | sample_7 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_8 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC NH2 only | sample_8 | isotropic | sample_conditions_1 |
3D HNCO | sample_8 | isotropic | sample_conditions_1 |
3D HNCA | sample_8 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_8 | isotropic | sample_conditions_1 |
3D HNCACB | sample_8 | isotropic | sample_conditions_1 |
3D HN(CA)CB | sample_8 | isotropic | sample_conditions_1 |
3D HN(CO)CACB | sample_8 | isotropic | sample_conditions_1 |
3D HN(COCA)CB | sample_8 | isotropic | sample_conditions_1 |
3D HN(CA)CO | sample_8 | isotropic | sample_conditions_1 |
3D HNCO | sample_8 | isotropic | sample_conditions_1 |
3D HNCA | sample_8 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_8 | isotropic | sample_conditions_1 |
3D HNCACB | sample_8 | isotropic | sample_conditions_1 |
3D HN(CA)CO | sample_8 | isotropic | sample_conditions_1 |
3D HNCACB | sample_8 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_9 | isotropic | sample_conditions_2 |
3D HNCO | sample_9 | isotropic | sample_conditions_2 |
3D HNCA | sample_9 | isotropic | sample_conditions_2 |
TOPSPIN, Bruker Biospin - collection
NMRPipe, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - processing
NMRDraw, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - processing
NMRView vJava 8.0.rc13, Johnson, One Moon Scientific - chemical shift assignment
PDB | |
DBJ | BAB14871 BAE26865 BAI47379 |
EMBL | CAA23696 CAA24495 CAA26485 CAA32012 CAA33404 |
GB | AAA40135 AAA42563 AAA42565 AAA42583 AAA49961 |
PRF | 0903255A |
REF | NP_001011413 NP_001020566 NP_001080738 NP_001104274 NP_001248263 |
SP | P00523 P00524 P00525 P00526 P05480 |
TPG | DAA23281 |
AlphaFold | P00523 P00524 P00525 P00526 P05480 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks